期刊文献+

胰腺癌组织Shh、Gli1、Sufu、TAK1、p-TAK1蛋白的表达及其临床意义 被引量:7

Expression and clinical significance of Shh, Gli1, Sufu, TAK1, p-TAK1 protein in pancreatic carcinoma
原文传递
导出
摘要 目的探讨Hedgehog信号通路重要成员Shh、Gli1、Sufu以及TAK1和磷酸化TAK1(p-TAK1)在胰腺癌组织中的表达及其与临床病理参数的相关性。方法应用免疫组化法检测38例手术切除的胰腺癌组织及其配对的癌旁胰腺组织中Shh、Gli1、Sufu、TAK1、P—TAK1蛋白的表达,分析它们与临床病理参数间的关系及它们相互间的关系。结果胰腺癌组织Shh、Gli1、Sufu、TAK1、P—TAK1蛋白的表达率分别为86.8%(33/38)、52.6%(20/38)、68.4%(26/38)、55.3%(21/38)、52.6%(20/38),而癌旁胰腺组织中的表达均为阴性。Gli1表达与肿瘤远处转移及临床分期呈正相关(r值分别为0.524、0.361,P值均〈0.05);Sufu表达与患者性别相关(r=-0.378,P〈0.05);TAK1表达与胰腺癌临床分期呈正相关(r=0.468,P〈0.05);p-TAK1表达与临床分期、肿瘤远处转移呈正相关(r值分别为0.418、0.361,P值均〈0.05)。胰腺癌组织中Gli1的表达水平与TAK1及p-TAK1呈正相关(P〈0.05)。结论Hedgehog信号通路及TAK1途径在胰腺癌的发生、发展中具有一定作用,且两条途径可能存在一定的相互作用。 Objective To investigate the expression of Hedgehog signaling pathway members, Shh, Glil, Sufu and TAK1 as well as phosphorylation-TAK1 (p-TAK1) protein in human pancreatic carcinoma tissues and to explore its relationship between the expression of proteins and the clinicopathologic parameters. Methods The expressions of Shh, Gill, Sufu, TAK1, p-TAK1 proteins in 38 samples of pancreatic cancer tissues and pairing adjacent normal pancreatic tissues were detected by immunohistoehemical method. The relationship among the proteins and the relationship between the expression of the proteins and the clinicopathologic parameters were examined. Results The positive expression rates of Shh, Glil, Sufu, TAK1, p-TAK1 protein in human pancreatic carcinoma were 86.8% ( 33/38 ), 52.6% (22/38), 68.4% (26/38), 55.3% (21/38), 52.6% (20/38), but they were not expressed in adjacent normal pancreatic tissues. Gift expression was positively related to distant metastasis and clinical staging (r =0. 524, 0.361, P 〈 0.05), Sufu expression was positively related to patient' s gender ( r = - 0. 378, P 〈 0.05 ), TAKI expression was positively related to clinical staging (r = 0.468, P 〈 0.05), p-TAK1 expression was positively related to clinical staging and distant metastasis ( r = 0. 418, 0. 361, P 〈 0.05). Glil expression was positively related to TAK1 and p-TAK1 expression in pancreatic cancer tissues (P 〈 0.05 ). Conclusions Hedgehog signaling pathway and p-TAK1 may play a role in the pathogenesis of pancreatic cancer, and the two pathways may interact with each other.
出处 《中华胰腺病杂志》 CAS 2013年第4期240-243,共4页 Chinese Journal of Pancreatology
基金 重大国际合作项目(30910103911)
关键词 胰腺肿瘤 免疫组织化学 HEDGEHOG信号通路 丝裂原激活蛋白激酶激酶类 Pancreatic neoplasm Immunohistochemistry Hedgehog signal pathway Mitogen- activated protein kinase kinases
  • 相关文献

参考文献8

  • 1Jones S, Zhang X, Parsons DW,et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 2008,321 : 1801-1806.
  • 2Nakashima H, Nakamura M, Yamaguehi H, et al. Nuclear factor- kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res ,2006,66:7041-7049.
  • 3Yamasaki A, Kameda C, Xu R, et al. Nuclear factor kappaB- activated monocytes contribute to pancreatic cancer progression through the production of Shh. Cancer Immunol Immunother, 2010, 59:675-686.
  • 4Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature, 2003,425 : 851-856.
  • 5Quint K, Stintzing S, Alinger B, el al. The expression pattern of PDX-1, SI-IH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer. Pancreatology, 2009,9 : 116-126.
  • 6王云锋,满晓华,高军,杜奕奇,龚燕芳,李兆申,金晶,吴红玉.SUFU在胰腺癌组织中的表达及其临床意义[J].中华胰腺病杂志,2010,10(6):418-420. 被引量:2
  • 7Melisi D, Xia Q, Paradiso G, et al. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. J Natl Cancer Inst, 2011,103 : 1190-1204.
  • 8Kasperczyk H, Baumann B, Debatin KM, et al. Characterization of sonic hedgehog as a novel NF-kappaB target gene that promotes NF-kappa B-mediated apoptosis resistance and tumor growth in vivo. FASEB J,2009,23:21-33.

二级参考文献5

  • 1Jemal A,Siegel R,Ward E,et al.Cancer Statistics,2008.CA Cancer J Clin,2008.58:71-96.
  • 2Cheng SY,Yue S.Role and regulation of human tumor suppressor SUFU in Hedgehog signaling.Adv Cancer Res,2008,101:29-43.
  • 3Varjosalo M,Li SP,Taipale J,et al.Divergence of hedgehog signal transduction mechanism between Drosophila and mammals.Dev Cell,2006,10:177-186.
  • 4Thayer SP,di Magliano MP,Heiser PW,et al.Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis.Nature,2003,425:851-856.
  • 5Humke EW,Dorn KV,Milenkovic L,et al.The output of Hedgehog signaling is controlled by the dynamic association between Suppressor of Fused and the Gli proteins.Genes Dev,2010,24:670-682.

共引文献1

同被引文献71

  • 1Esophageal cancer: epidemiology, pathogenesis and prevention [J]. Nat Clin Pract Gastroenterol Hepatol, 2008,5(9) :517-526.
  • 2Mimura K, Shiralshi K, Mueller A, et al. The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer [ J ]. J Immunol, 2013,191 ( 12 ) : 6261-6272.
  • 3Abdel-Latif MM, Kelleher D, Reynolds JV. Potential role of NF-kappaB in esophageal adenocareinoma: as an emerging molecular target [J]. J Surg Res, 2009, 153(1) : 172-180.
  • 4Zheng ST, Huo Q, Tuerxun A, et al. The expression and activation of ERK/MAPK pathway in human esophageal cancer celt line EC9706 [J]. Mol Biol Rep, 2011,38(2) :865-872.
  • 5Yousif NG, A1-Amran FG, Hadi N, et al. Expression of IL-32 modulates NF-kappaB and p38 MAP kinase pathways in human esophageal cancer[J]. Cytokine, 2013,61 ( 1 ) : 223-227.
  • 6Abdel-Latif MM, O'Riordan J, Windle HI, et al. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy [ J ]. Ann Surg, 2004,239 (4) : 491-500.
  • 7Dai L, Aye TC, Liu XY, et al. TAK1, more than just innate immunity [J ]. IUBMB Life, 2012,64(10) : 825-834.
  • 8Sakurai H. Targeting of TAK1 in inflammatory disorders and cancer [J]. Trends Pharmacol Sci, 2012,33(10) :522-530.
  • 9Melisi D, Xia Q, Paradiso G, et al. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1 [J]. J Natl CancerInst, 2011,103(15) : 1190-1204.
  • 10Singh A, Sweeney MF, Yu M, et al. TAKI inhibition promotes apoptosis in KRAS-dependent colon cancers [J]. Cell, 2012, 148(4) :639-650.

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部